Category: Life Sciences
Global Life Sciences
-
Cerebrospinal Fluid (CSF) Management Devices
... is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Shunts, one of the segments analyzed in the report, is expected to record a 4.1% CAGR ... Read More
-
Cervical Total Disc Replacement Devices
... is expected to reach US$12.1 Billion by 2030, growing at a CAGR of 18.3% over the analysis period 2023-2030. Metal-on-Biocompatible Material, one of the segments analyzed in the report, is expected to record a 19.3% ... Read More
-
Silage Additives
... at a CAGR of 4.8% over the analysis period 2023-2030. Legumes Application, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.7 Billion by the end of ... Read More
-
Bioprocess Containers
... at a CAGR of 23.6% over the analysis period 2023-2030. Upstream Processes Application, one of the segments analyzed in the report, is expected to record a 26.4% CAGR and reach US$19.6 Billion by the end ... Read More
-
Blood Pressure Transducers
... by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Disposable Transducers, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$512.1 Million by ... Read More
-
Body Contouring Devices
... by 2030, growing at a CAGR of 14.3% over the analysis period 2023-2030. Minimally Invasive Devices, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$7.4 Billion ... Read More
-
Brewing Enzymes
... at a CAGR of 5.7% over the analysis period 2023-2030. Beer Application, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$434.2 Million by the end of ... Read More
-
Case Management
... at a CAGR of 10.2% over the analysis period 2023-2030. Case Management Solutions, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$11.4 Billion by the end ... Read More
-
Cell Counting
... at a CAGR of 5.3% over the analysis period 2023-2030. Cell Counting Consumables, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$12.9 Billion by the end ... Read More
-
Cell Viability Assays
... by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. Consumables Component, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$5.3 Billion by ... Read More
-
Cell Signaling
... at a CAGR of 5.4% over the analysis period 2023-2030. Consumables Component, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$4.5 Billion by the end of ... Read More
-
Fish Oil Products
... by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Blue Whiting Species, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$811.9 Million ... Read More
-
Food Grade Glycerin
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Personal Care Application, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$937.1 Million ... Read More
-
Foot and Ankle Devices
... reach US$7.3 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Orthopedic Implants & Devices, one of the segments analyzed in the report, is expected to record a 5.7% CAGR ... Read More
-
Gel Permeation Chromatography Systems
... reach US$2.7 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Pharma & Biotech Companies End-Use, one of the segments analyzed in the report, is expected to record a 5.8% ... Read More
-
Medical Aesthetic Devices
... by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Facial Aesthetic Products, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$9.2 Billion ... Read More
-
Medical Device Connectivity
... by 2030, growing at a CAGR of 21.1% over the analysis period 2023-2030. Wireless Technology, one of the segments analyzed in the report, is expected to record a 22.1% CAGR and reach US$10.1 Billion by ... Read More
-
Medical Device Testing
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Testing Service, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$7.6 Billion by ... Read More
-
Medical Composites
... at a CAGR of 8.4% over the analysis period 2023-2030. Dental Application, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$936.0 Million by the end of ... Read More
-
Medical Power Supply
... by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Enclosed Power Supply, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.2 Billion ... Read More
-
Medical Tapes
... at a CAGR of 4.7% over the analysis period 2023-2030. Wounds & Injuries Application, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.8 Billion by the ... Read More
-
Meta Xylene
... at a CAGR of 4.7% over the analysis period 2023-2030. Isophthalic Acid Production Application, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.5 Billion by the ... Read More
-
Metal Nanoparticles
... at a CAGR of 9.3% over the analysis period 2023-2030. Silver Nanoparticles, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$1.6 Billion by the end of ... Read More
-
Microgrid as a Service (MaaS)
... is expected to reach US$6.6 Billion by 2030, growing at a CAGR of 15.7% over the analysis period 2023-2030. Grid Connected MaaS, one of the segments analyzed in the report, is expected to record a ... Read More
-
Mixed Tocopherols
... at a CAGR of 4.8% over the analysis period 2023-2030. Cosmetics Application, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.0 Billion by the end of ... Read More